Literature DB >> 12684770

Bronchiolar columnar cell dysplasia--genetic analysis of a novel preneoplastic lesion of peripheral lung.

Reinhard Ullmann1, Massimo Bongiovanni, Iris Halbwedl, Susanna Petzmann, Margit Gogg-Kammerer, Anna Sapino, Mauro Papotti, Gianni Bussolati, Helmut H Popper.   

Abstract

Atypical adenomatous hyperplasia is the only known precursor lesion of lung adenocarcinomas (ACs) so far. Here, we describe a new dysplastic lesion in the bronchioles of peripheral lung for which we propose the name bronchiolar columnar cell dysplasia (BCCD). Eight of fourteen BCCDs were successfully analyzed by means of comparative genomic hybridization (CGH). The average number of chromosomal aberrations was 2.6 in BCCD and 14.7 in concomitant AC. Among the aberrations were losses of 3p, 9, 13, 14 and gains of 1q, 17, 19q and 20q. Summarizing our data from morphological and genetic analysis, we conclude that BCCD is a preneoplasia of the bronchiolar epithelium and most probably represents an additional precursor lesion of lung adenocarcinomas.

Entities:  

Mesh:

Year:  2003        PMID: 12684770     DOI: 10.1007/s00428-003-0797-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Loss of heterozygosity on chromosome arm 11q in lung carcinoids.

Authors:  S Petzmann; R Ullmann; H Klemen; H Renner; H H Popper
Journal:  Hum Pathol       Date:  2001-03       Impact factor: 3.466

Review 2.  Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.

Authors:  M Mori; S K Rao; H H Popper; P T Cagle; A E Fraire
Journal:  Mod Pathol       Date:  2001-02       Impact factor: 7.842

3.  Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.

Authors:  M Yamasaki; Y Takeshima; S Fujii; S Kitaguchi; M Matsuura; K Tagawa; K Inai
Journal:  Pathol Int       Date:  2000-10       Impact factor: 2.534

4.  3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.

Authors:  J Sanz-Ortega; M C Saez; E Sierra; A Torres; J L Balibrea; F Hernando; J Sanz-Esponera; M J Merino
Journal:  J Pathol       Date:  2001-11       Impact factor: 7.996

5.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

Authors:  J Hung; Y Kishimoto; K Sugio; A Virmani; D D McIntire; J D Minna; A F Gazdar
Journal:  JAMA       Date:  1995-06-28       Impact factor: 56.272

6.  Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

Authors:  I I Wistuba; J Berry; C Behrens; A Maitra; N Shivapurkar; S Milchgrub; B Mackay; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

7.  Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas.

Authors:  S Michelland; S Gazzeri; E Brambilla; M Robert-Nicoud
Journal:  Cancer Genet Cytogenet       Date:  1999-10-01

8.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

9.  Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.

Authors:  L Thiberville; P Payne; J Vielkinds; J LeRiche; D Horsman; G Nouvet; B Palcic; S Lam
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

10.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.

Authors:  Y Kishimoto; K Sugio; J Y Hung; A K Virmani; D D McIntire; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

View more
  7 in total

Review 1.  The effects of carbon nanotubes on lung and dermal cellular behaviors.

Authors:  Sudjit Luanpitpong; Liying Wang; Yon Rojanasakul
Journal:  Nanomedicine (Lond)       Date:  2014-05       Impact factor: 5.307

Review 2.  [Preneoplastic lesions of pulmonary carcinoma].

Authors:  L Bubendorf
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Carbon nanotubes induce malignant transformation and tumorigenesis of human lung epithelial cells.

Authors:  Liying Wang; Sudjit Luanpitpong; Vincent Castranova; William Tse; Yongju Lu; Varisa Pongrakhananon; Yon Rojanasakul
Journal:  Nano Lett       Date:  2011-06-09       Impact factor: 11.189

4.  Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells.

Authors:  Todd A Stueckle; Yongju Lu; Mary E Davis; Liying Wang; Bing-Hua Jiang; Ida Holaskova; Rosana Schafer; John B Barnett; Yon Rojanasakul
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-13       Impact factor: 4.219

5.  Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.

Authors:  Angelica Sonzogni; Fabrizio Bianchi; Alessandra Fabbri; Mara Cossa; Giulio Rossi; Alberto Cavazza; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Benedetta Picciani; Barbara Valeri; Ugo Pastorino; Giuseppe Pelosi
Journal:  J Pathol Clin Res       Date:  2017-03-22

Review 6.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

7.  Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes.

Authors:  Sudjit Luanpitpong; Liying Wang; Vincent Castranova; Yon Rojanasakul
Journal:  Part Fibre Toxicol       Date:  2014-05-11       Impact factor: 9.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.